{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:45:41Z","timestamp":1794048341472,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.vaccine.2020.10.077","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T10:18:05Z","timestamp":1604571485000},"page":"8175-8184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection"],"prefix":"10.1016","volume":"38","author":[{"given":"Aleksandra E.","family":"Sikora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Le Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin I.","family":"Baarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Darnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian G.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard A.","family":"Zielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine A.","family":"Bonventre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Jerse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2020.10.077_b0005","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1586\/14760584.2015.1091732","article-title":"Recombinant bacterial lipoproteins as vaccine candidates","volume":"14","author":"Leng","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"43","key":"10.1016\/j.vaccine.2020.10.077_b0010","doi-asserted-by":"crossref","first-page":"15850","DOI":"10.1074\/jbc.RA119.010120","article-title":"Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen Clostridioides difficile","volume":"294","author":"Bradshaw","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2020.10.077_b0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fcimb.2013.00005","article-title":"Burkholderia vaccines: are we moving forward?","volume":"3","author":"Choh","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.077_b0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/IAI.00682-10","article-title":"Lipoproteins of bacterial pathogens","volume":"79","author":"Kovacs-Simon","year":"2011","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2020.10.077_b0025","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.4049\/jimmunol.180.9.6149","article-title":"Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis","volume":"180","author":"Henneke","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.077_b0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/femsre\/fuu006","article-title":"The molecular mechanism of bacterial lipoprotein modification\u2013how, when and why?","volume":"39","author":"Buddelmeijer","year":"2015","journal-title":"FEMS Microbiol Rev"},{"issue":"23","key":"10.1016\/j.vaccine.2020.10.077_b0035","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1111\/febs.12041","article-title":"Lipoproteins in bacteria: structures and biosynthetic pathways","volume":"279","author":"Nakayama","year":"2012","journal-title":"FEBS J"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.077_b0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00763177","article-title":"Lipoproteins in bacteria","volume":"22","author":"Hayashi","year":"1990","journal-title":"J Bioenerg Biomembr"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.077_b0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tim.2015.11.006","article-title":"Surface-Exposed Lipoproteins: An Emerging Secretion Phenomenon in Gram-Negative Bacteria","volume":"24","author":"Wilson","year":"2016","journal-title":"Trends Microbiol"},{"issue":"1679","key":"10.1016\/j.vaccine.2020.10.077_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rstb.2015.0030","article-title":"Outer membrane lipoprotein biogenesis: Lol is not the end","volume":"370","author":"Konovalova","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.077_b0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12272-009-1400-1","article-title":"Innovative vaccine production technologies: the evolution and value of vaccine production technologies","volume":"32","author":"Bae","year":"2009","journal-title":"Arch Pharm Res"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.077_b0060","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/bc100083d","article-title":"Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis","volume":"21","author":"Fischer","year":"2010","journal-title":"Bioconjug Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.077_b0065","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","article-title":"Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea","volume":"15","author":"Zielke","year":"2016","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.077_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.00898-16","article-title":"MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies","volume":"85","author":"Semchenko","year":"2017","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.077_b0075","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.10.077_b0080","unstructured":"CDC. 2018 Sexually Transmitted Diseases Surveillance. 2019 2019-10-09T12:34:07Z; Available from: https:\/\/www.cdc.gov\/std\/stats18\/default.htm."},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.077_b0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpsychores.2013.12.009","article-title":"Relationship between psychiatric disorders and sexually transmitted diseases in a nationally representative sample","volume":"76","author":"Magidson","year":"2014","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.077_b0090","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.idc.2005.07.003","article-title":"Gonococcal arthritis (disseminated gonococcal infection)","volume":"19","author":"Rice","year":"2005","journal-title":"Infect Dis Clin North Am"},{"issue":"5747","key":"10.1016\/j.vaccine.2020.10.077_b0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.1.5747.482","article-title":"Septic gonococcal dermatitis","volume":"1","author":"Barr","year":"1971","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.077_b0100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/infdis\/132.2.204","article-title":"Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements","volume":"132","author":"Knapp","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.10.077_b0105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu Rev Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.077_b0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40272-018-0310-4","article-title":"Sexually Transmitted Infections in Pregnant Women: Integrating Screening and Treatment into Prenatal Care","volume":"20","author":"Lochner","year":"2018","journal-title":"Pediatric Drugs"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.077_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"issue":"25","key":"10.1016\/j.vaccine.2020.10.077_b0120","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.vaccine.2020.10.077_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.10.077_b0130","unstructured":"England PH. UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad, in Health Protection Report; 2018. p. 1-4."},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.077_b0135","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1074\/mcp.M113.029538","article-title":"Quantitative proteomics of the Neisseria gonorrhoeae cell envelope and membrane vesicles for the discovery of potential therapeutic targets","volume":"13","author":"Zielke","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.077_b0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1074\/mcp.RA118.001125","article-title":"Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants","volume":"18","author":"El-Rami","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"5459","key":"10.1016\/j.vaccine.2020.10.077_b0145","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.10.077_b0150","doi-asserted-by":"crossref","unstructured":"Zielke RA, Gafken PR, Sikora AE. Quantitative proteomic analysis of the cell envelopes and native membrane vesicles derived from gram-negative bacteria. Curr Protoc Microbiol 2014;34:1F 3 1\u20131F 3 16.","DOI":"10.1002\/9780471729259.mc01f03s34"},{"key":"10.1016\/j.vaccine.2020.10.077_b0155","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3389\/fimmu.2018.02793","article-title":"Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines","volume":"9","author":"Baarda","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.077_b0160","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","article-title":"Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice","volume":"67","author":"Jerse","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.10.077_b0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fmicb.2011.00107","article-title":"Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections","volume":"2","author":"Jerse","year":"2011","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.077_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000323","article-title":"Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody","volume":"17","author":"Gulati","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2020.10.077_b0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.077_b0180","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/pro.3694","article-title":"Structures of the Neisseria meningitides methionine-binding protein MetQ in substrate-free form and bound to l- and d-methionine isomers","volume":"28","author":"Nguyen","year":"2019","journal-title":"Protein Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.077_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016957","article-title":"The human serum metabolome","volume":"6","author":"Psychogios","year":"2011","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.077_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007081","article-title":"SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection","volume":"14","author":"Zielke","year":"2018","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.077_b0195","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/IAI.00825-08","article-title":"A strain-specific catalase mutation and mutation of the metal-binding transporter gene mntC attenuate Neisseria gonorrhoeae in vivo but not by increasing susceptibility to oxidative killing by phagocytes","volume":"77","author":"Wu","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.10.077_b0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fmicb.2011.00124","article-title":"Vaccines for gonorrhea: can we rise to the challenge?","volume":"2","author":"Zhu","year":"2011","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.077_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003559","article-title":"Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection","volume":"9","author":"Gulati","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.10.077_b0210","series-title":"International Pathogenic Neisseria Conference","article-title":"Development of MtrE, the outer membrane channel of the MtrCDE and FarAB, MtrE active efflux pump systems, as a gonorrhea vaccine","author":"Amanda DeRocco","year":"2014"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.077_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00421-17","article-title":"Intravaginal Administration of Interleukin 12 during Genital Gonococcal Infection in Mice Induces Immunity to Heterologous Strains of Neisseria gonorrhoeae","volume":"3","author":"Liu","year":"2018","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.077_b0220","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1128\/IAI.73.11.7558-7568.2005","article-title":"Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles","volume":"73","author":"Zhu","year":"2005","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.077_b0225","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2005.11.006","article-title":"Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens","volume":"24","author":"Jacobsson","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.077_b0230","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/infdis\/jir301","article-title":"Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis","volume":"204","author":"Easton","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.077_b0235","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4049\/jimmunol.162.4.2291","article-title":"Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria","volume":"162","author":"Elkins","year":"1999","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.077_b0240","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/IAI.74.3.1944-1948.2006","article-title":"A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei","volume":"74","author":"Waag","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.077_b0245","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.4049\/jimmunol.161.5.2428","article-title":"CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge","volume":"161","author":"Krieg","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.077_b0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/IAI.70.1.147-152.2002","article-title":"CpG oligodeoxynucleotides enhance host defense during murine tuberculosis","volume":"70","author":"Juffermans","year":"2002","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.077_b0255","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.4049\/jimmunol.173.8.5148","article-title":"CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection","volume":"173","author":"Deng","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.077_b0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.077_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130713","article-title":"Neisseria gonorrhoeae Modulates Immunity by Polarizing Human Macrophages to a M2 Profile","volume":"10","author":"Ortiz","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.10.077_b0270","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/127017","article-title":"Neisseria gonorrhoeae induces a tolerogenic phenotype in macrophages to modulate host immunity","volume":"2013","author":"Escobar","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.vaccine.2020.10.077_b0275","unstructured":"TRUMENBA [Package Insert]; 2018."},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.077_b0280","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.077_b0285","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/mi.2009.139","article-title":"Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection","volume":"3","author":"Feinen","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2020.10.077_b0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmicb.2011.00052","article-title":"New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host","volume":"2","author":"Liu","year":"2011","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.077_b0295","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mi.2012.12","article-title":"Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-beta-dependent mechanisms","volume":"5","author":"Liu","year":"2012","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.077_b0300","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/mi.2013.36","article-title":"Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells","volume":"7","author":"Liu","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.077_b0305","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:32Z","timestamp":1759402172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":61,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0264410X20313979"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.077","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.19.161646","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}